Newsroom

Articles

Articles

Resistance to first-line antibiotic piperacillin/tazobactam to grow from 12% to 25% in the UK by 2033

story

Resistance to first-line antibiotic piperacillin/tazobactam to grow from 12% to 25% in the UK by 2033

Published by Airfinity

Feb 21, 2024

Airfinity announces Alexander Karle, former CEO of Evaluate, as newest advisor

story

Airfinity announces Alexander Karle, former CEO of Evaluate, as newest advisor

Published by Airfinity

Dec 15, 2023

Airfinity announces Dirk Bernhardt as new Chief Finance Officer

story

Airfinity announces Dirk Bernhardt as new Chief Finance Officer

Published by Airfinity

Nov 17, 2023

Airfinity sponsors Team Ocean Warrior, the first ever Scandinavian boat to row across the Mid Pacific Ocean

story

Airfinity sponsors Team Ocean Warrior, the first ever Scandinavian boat to row across the Mid Pacific Ocean

Published by Airfinity

May 9, 2023

Airfinity launches free obesity market newsletter

story

Airfinity launches free obesity market newsletter

Published by Airfinity

Oct 26, 2023

Climate change and vector-borne disease outbreaks: what you need to know

story

Climate change and vector-borne disease outbreaks: what you need to know

Published by Airfinity

Sep 18, 2023

Airfinity Shortlisted for DataIQ Awards 2023 ‘Best Data Story or Data Visualisation’

story

Airfinity Shortlisted for DataIQ Awards 2023 ‘Best Data Story or Data Visualisation’

Published by Airfinity

Jun 30, 2023

Airfinity Launches an RNA Therapeutics and Vaccine Intelligence Tool

story

Airfinity Launches an RNA Therapeutics and Vaccine Intelligence Tool

Published by Airfinity

May 16, 2023

Former Editor of The Economist joins Airfinity as advisor

story

Former Editor of The Economist joins Airfinity as advisor

Published by Airfinity

Jan 17, 2023

Airfinity’s COVID-19 forecast for China infections and deaths

story

Airfinity’s COVID-19 forecast for China infections and deaths

Published by Airfinity

Jan 17, 2023

airfinity logo

story

Airfinity hosting industry leader roundtable on the future of the RSV market

Published by Airfinity

Jan 3, 2023

Airfinity launches new HPV solution for prophylactic vaccines and treatments

story

Airfinity launches new HPV solution for prophylactic vaccines and treatments

Published by Airfinity

Dec 12, 2022

China approves second intranasal vaccine

story

China approves second intranasal vaccine

Published by Airfinity

Dec 7, 2022

Airfinity launches intelligence tool to drive innovation in AMR research

story

Airfinity launches intelligence tool to drive innovation in AMR research

Published by Airfinity

Nov 18, 2022

Airfinity expands coverage to include Paroxysmal Nocturnal Haemoglobinuria candidates

story

Airfinity expands coverage to include Paroxysmal Nocturnal Haemoglobinuria candidates

Published by Airfinity

Nov 1, 2022

GSK releases positive data on its RSV vaccine for older adults, RSV OA

story

GSK releases positive data on its RSV vaccine for older adults, RSV OA

Published by Airfinity

Oct 13, 2022

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

story

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Published by Airfinity

Oct 10, 2022

Airfinity provides real-time mapping on the global antiviral landscape to PAD initiative

story

Airfinity provides real-time mapping on the global antiviral landscape to PAD initiative

Published by Airfinity

Sep 14, 2022

Airfinity shortlisted at the Reuters Pharma Awards 2022

story

Airfinity shortlisted at the Reuters Pharma Awards 2022

Published by Airfinity

Sep 12, 2022

Airfinity appoints its first ever Chief Product Officer, Colin Willians

story

Airfinity appoints its first ever Chief Product Officer, Colin Willians

Published by Airfinity

Jul 4, 2022

airfinity logo

story

Airfinity launched ID-Vx and ID-Tx

Published by Airfinity

Jul 8, 2022

Airfinity launches Influenza and RSV Commercial solutions

story

Airfinity launches Influenza and RSV Commercial solutions

Published by Airfinity

Jul 6, 2022

Key factors hindering global oral antiviral uptake

story

Key factors hindering global oral antiviral uptake

Published by Airfinity

Jun 9, 2022

The AAV Gene Therapy Regulatory Landscape

story

The AAV Gene Therapy Regulatory Landscape

Published by Airfinity

Jun 1, 2022

What does Monkeypox teach us about pandemic preparedness?

story

What does Monkeypox teach us about pandemic preparedness?

Published by Airfinity

May 24, 2022

Airfinity’s Q1 COVID-19 vaccine revenue forecast more accurate than market consensus

story

Airfinity’s Q1 COVID-19 vaccine revenue forecast more accurate than market consensus

Published by Airfinity

May 12, 2022

airfinity logo

story

South Africa's fifth wave potentially driven by new Omicron subvariants

Published by Airfinity

May 3, 2022

airfinity logo

story

ECCMID2022: Day 3 Post-Conference Coverage

Published by Airfinity

Apr 26, 2022

airfinity logo

story

Janssen’s Carvykti (cilta-cel) FDA approval sets the pace for a cell therapy race in multiple myeloma

Published by Airfinity

Mar 1, 2022

airfinity logo

story

Comparing the burden of COVID-19 to seasonal flu: what does the data say?

Published by Airfinity

Jan 21, 2022

airfinity logo

story

Pfizer oral COVID-19 pill gets U.S. authorisation

Published by Airfinity

Dec 22, 2021

airfinity logo

story

FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year

Published by Airfinity

Dec 23, 2021

airfinity logo

story

Limited supply of new Omicron vaccines for most of next year

Published by Airfinity

Nov 30, 2021

airfinity logo

story

Hungary, Belgium and the Netherlands face potential future lockdowns, according to Airfinity.

Published by Airfinity

Nov 19, 2021

airfinity logo

story

Oncopeptides withdraws its peptide-drug conjugate (PCD) Pepaxto from the US market

Published by Airfinity

Oct 25, 2021

Accurately predicting the vaccine market

story

Accurately predicting the vaccine market

Published by Airfinity

Nov 9, 2021

airfinity logo

story

UK hospitals could be overwhelmed by COVID and flu cases, potentially leading to further restrictions

Published by Airfinity

Oct 27, 2021

airfinity logo

story

Elderly vaccine coverage has greatest impact on hospitalisations

Published by Airfinity

Oct 20, 2021

Airfinity Launches New Influenza and RSV Intelligence Solution

story

Airfinity Launches New Influenza and RSV Intelligence Solution

Published by Airfinity

Oct 14, 2021

Airfinity launches new COVID-19 Vaccine Supply and Production Platform

story

Airfinity launches new COVID-19 Vaccine Supply and Production Platform

Published by Airfinity

Aug 18, 2021

airfinity logo

story

Moderna more effective than Pfizer in direct comparison against the Delta variant

Published by Airfinity

Aug 18, 2021

airfinity logo

story

Waning immunity in Israel as infections rise five months after 75% of adults fully vaccinated

Published by Airfinity

Aug 18, 2021

Pandemic focuses the need for a data-driven antiviral strategy

story

Pandemic focuses the need for a data-driven antiviral strategy

Published by Airfinity

Jul 22, 2021

airfinity logo

story

Airfinity launches new Surplus Doses Analysis Tool

Published by Airfinity

Jul 23, 2021

How Much Vaccine Will Be Produced This Year?

story

How Much Vaccine Will Be Produced This Year?

Published by Airfinity

May 20, 2021

The need for novel lipid lowering therapeutics

story

The need for novel lipid lowering therapeutics

Published by Airfinity

May 26, 2021

Airfinity launches Vaccine Efficacy Meta-Analysis tool

story

Airfinity launches Vaccine Efficacy Meta-Analysis tool

Published by Airfinity

Jul 9, 2021

airfinity logo

story

EU and Canada vaccination rate has increased, while the UK and USA slows

Published by Airfinity

Jul 21, 2021

airfinity logo

story

Immune response profiles triggered by SARS-CoV-2 infection or vaccines are notably different

Published by Airfinity

Jul 15, 2021

airfinity logo

story

New People Protected Module

Published by Airfinity

Jul 2, 2021

airfinity logo

story

While cases keep rising, UK population better protected from severe COVID

Published by Airfinity

Jul 7, 2021

airfinity logo

story

Sinovac is the most used vaccine in the world, with 943m doses delivered

Published by Airfinity

Jul 7, 2021

airfinity logo

story

Pfizer/BioNTech vaccine efficacy and the Delta variant

Published by Airfinity

Jul 6, 2021

airfinity logo

story

China administers its billionth vaccine dose, on track to be fully vaccinated by the end of 2021

Published by Airfinity

Jun 23, 2021

airfinity logo

story

Delta variant is now the second most prevalent variant of concern (VoC) globally

Published by Airfinity

Jun 23, 2021

airfinity logo

story

Euro 2020 puts a spotlight on cardiovascular health

Published by Airfinity

Jun 16, 2021

airfinity logo

story

Global Vaccination Forecast

Published by Airfinity

May 12, 2021

airfinity logo

story

Vaccines for the children

Published by Airfinity

May 6, 2021

airfinity logo

story

India struggling to vaccinate with supply shortage, despite export ban

Published by Airfinity

May 6, 2021

airfinity logo

story

Halting India's Vaccine Exports: The Fallout

Published by Airfinity

Apr 26, 2021

airfinity logo

story

How Much Surplus Vaccine Will the U.S. Have?

Published by Airfinity

Apr 16, 2021

airfinity logo

story

Denmark halts AstraZeneca altogether

Published by Airfinity

Apr 14, 2021

Impact of European Countries Halting AZN

story

Impact of European Countries Halting AZN

Published by Airfinity

Mar 16, 2021

Vaccine Candidates' Cumulative Production

story

Vaccine Candidates' Cumulative Production

Published by Airfinity

Feb 28, 2021